News

Because Canada has a universal healthcare system, financial differences in access to care cannot fully explain the observed ...
BACKGROUND: Direct reprogramming of fibroblasts to cardiomyocytes is a potentially curative strategy for ischemic heart ...
For younger acute myocardial infarction (AMI) survivors, living in marginalized neighborhoods is associated with adverse ...
Secondary analysis findings from the EMPACT-MI trial highlight empagliflozin's significant cardiovascular and kidney benefits when initiated soon after an acute myocardial infarction.
The triggering receptor expressed on myeloid cells 2 (TREM2) plays a pivotal role in the activation of myeloid cells and is currently being investigated as a potential therapeutic target in several ...
Recognising the symptoms of a heart attack and stroke early and taking preventive steps can be beneficial for people. In this ...
The Medical City (TMC) has earned a spot in Newsweek and Statista’s 2025 list of top-performing hospitals across the Asia ...
Australia: A new study published in Circulation: Cardiovascular Imaging suggests that a novel automated score that ...
Patients with inflammatory arthritis would benefit from vaccination against herpes zoster, with the Shingrix vaccine showing a crude effectiveness of 50%.
For patients with acute MI at increased risk for HF, empagliflozin showed cardiorenal benefits and was safe to initiate early ...
The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.
A secondary analysis of a large trial shows that exposure to the HIV drug abacavir is linked to an elevated risk for major ...